SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camson Bio Technologies board to consider Dividend

21 May 2014 Evaluate

Camson Bio Technologies has informed that a meeting of the Board of Directors of the company will be held on May 28, 2014 to consider, approve and take on record the Audited Financial Results of the company for the last quarter and year ended March 31, 2014. 2014 and the Board may consider appropriation of profits also along with the Audited Financials & Consideration of dividend.

The above information is a part of company’s filings submitted to BSE.

Camson Bio Share Price

3.31 0.00 (0.00%)
11-May-2020 18:01 View Price Chart
Peers
Company Name CMP
Venkys India 1589.25
Mangalam Global Ent 12.93
Kaveri Seed 924.50
Regaal Resources 85.04
Simran Farms 165.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×